Summary
In order to perform measurement of PRL binding and to improve the knowledge of pathophysiological variations in human mammary cancers, we have investigated in detail the binding characteristics of PRL in membranes prepared from these tumors. The optimization of the assay requires the selection of membranous components of light density (<1.17); the tracer could be either125I-PRL after affinity purification on PRL receptors or125I-hGH without a purification step. It is favorable to utilize a high amount of protein and 200 000 cpm (2 ng) of tracer. Demonstration of the presence of receptors for PRL with a high affinity (Kd = 3 × 10−10 M) in breast cancer is presented. The hormonal specificity of these receptors is studied: only lactogenic hormones (hGH, oPRL, hPRL, and hPL) are able to compete for binding of125I-hPRL whereas bGH or insulin are without effect. Considering the known effect of PRL on cell multiplication, it is tempting to suggest that this hormone could have a crucial role in the development of breast tumor in humans and that therapies which would suppress secretion of PRL and GH could be beneficial.
References
Barrett A, Morgan L, Ragatt PR, Hobbs JR: Bromocriptine in the treatment of advanced breast cancer. Clin Oncol 2:373–377, 1976
Bonneterre J, Peyrat JP, Vandewalle B, Beuscart R, Vie MC, Cappelaere P: Prolactin receptors in human breast cancer. Eur J Cancer Clin Oncol 18:1152–1162, 1982
Ceriani RL, Contesso GP, Nataf BM: Hormone requirement for growth and differentiation of the human mammary gland in organ culture. Cancer Res 32:2190–2196, 1972
Di Carlo R, Muccioli G: Prolactin receptor in human mammary carcinoma. Tumori 65:695–792, 1979
Dilley WG, Kister SJ: In vitro stimulation of human breast tissue by human PRL. J Natl Cancer Inst 55:35–36, 1975
Djiane J, Durand P, Kelly PA: Evolution of prolactinreceptors in rabbit mammary gland during pregnancy and lactation. Endocrinology 100:1348–1356, 1977
Djiane J, Houdebine LM, Kelly PA: Down-regulation of prolactin receptors in rabbit mammary gland: differential subcellular localization. Proc Soc Exp Biol Med 168:378–381, 1981
Djiane J, Houdebine LM, Kelly PA: Correlation between prolactin-receptor interaction, down-regulation of receptors, and stimulation of casein and deoxyribonucleic acid biosynthesis in rabbit mammary gland explants. Endocrinology 110:791–795, 1982
European Breast Cancer Group: Clinical trial of 2-bromocriptine (CB 154) in advanced breast cancer. Eur J Cancer 8:155–156, 1972
European Breast Cancer Group: Clinical trial of the cyclic imide 1-(morpholinomethyl)-4-phytalimido-piperidinedione-2,6 (CG 603) in advanced breast cancer. Eur J Cancer 8:157–158, 1972
Greenwood FG, Hunter WH, Glover JS: The preparation of125I-labeled human growth hormone of high specific radioactivity. Biochem J 89:114–123, 1963
Holdaway JM, Friesen HG: Hormone binding by human mammary carcinoma. Cancer Res 37:1946–1952, 1977
Kelly PA, Leblanc G, Djiane J: Estimation of total prolactin binding sites after in vitro desaturation. Endocrinology 104:1631–1638, 1979
Kleejer-Anderson P, Buehring G: Effect of hormones on growth rates of malignant and nonmalignant human mammary epithelia in cell culture. In Vitro 16:491–501, 1980
Lowry OH, Rosebrough NJ, Farr A, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275, 1951
Malarkey WB, Kennedy M, Allred LE, Milo G: Physiological concentrations of prolactin can promote the growth of human breast tumor cells in cultures. J Clin Endocrinol Metab 56:673–677, 1983
Meites J: Relation of the neuro-endocrine system to the development and growth of experimental mammary tumors. J Neural Transmission 48:25–42, 1980
Partridge RK, Hahnel R: Prolactin receptors in human breast carcinoma. Cancer 43:643–646, 1979
Peyrat JPh, Dewailly D, Djiane J, Kelly PA, Vandewalle B, Bonneterre J, Lefebvre J: Total prolactin binding sites in human breast cancer biopsies. Breast Cancer Res Treat 1:369–373, 1981
Rae-Venter B, Nemoto T, Schneider SL, Dao TL: Prolactin binding by human mammary carcinoma: relationship to estrogen receptor protein concentration and patient age. Breast Cancer Res Treat 1:233–243, 1981
Scatchard G: An attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–673, 1949
Shiu RPC, Friesen HG: Properties of a prolactin receptor from the rabbit mammary gland. Biochem J 140:301–311, 1974
Shiu RPC, Friesen HG: Solubilization and purification of a prolactin receptor from the rabbit mammary gland. J Biol Chem 249:7902–7911, 1974
Topper YJ, Freeman CS: Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60:1049–1106, 1980
Turcot-Lemay L, Kelly PA: Prolactin receptors in human breast tumors. J Natl Cancer Inst 68:381–383, 1982
Welsch CW, De Itturi GC, Brennan HJ: DNA synthesis of human, mouse, and rat mammary carcinomas in vitro. Influence of insulin and prolactin. Cancer 38:1272–1281, 1976
Welsch CW, Nagasawa H: Prolactin and murine mammary tumorigenesis. A review. Cancer Res 37:951–963, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peyrat, JP., Djiane, J., Kelly, P.A. et al. Characterization of prolactin receptors in human breast cancer. Breast Cancer Res Tr 4, 275–281 (1984). https://doi.org/10.1007/BF01806039
Issue Date:
DOI: https://doi.org/10.1007/BF01806039